Global Coagulation Testing market to grow at a CAGR of 5.62 percent by 2018

Global Coagulation Testing Market 2014-2018 is a new market research publication announced by Reportstack. Coagulation tests help in measuring the clotting ability of blood. Clotting is the process of blood converting from liquid into gel form. Coagulation tests are performed to analyze clotting disorders such as hemorrhage and thrombosis. Coagulation tests include complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving patients' quality of life.

The analysts forecast that the Global Coagulation Testing market to grow at a CAGR of 5.62 percent over the period 2013-2018. The Global Coagulation Testing market can be segmented into the revenue generated from end- user application such as: Point-of-Care Coagulation Testing and Home Diagnostics.
The report Global Coagulation Testing market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Coagulation Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
Key Vendors
• Abbott Laboratories
• Danaher 
• F. Hoffmann-La Roche 
• Sysmex 
Other Prominent Vendors

• Alere 
• Cepheid 
• CoaguSense 
• HYPEN BioMed
• Helena Laboratories
• LABiTec
• Medtronic
• Siemens
• Sienco
• Stago 

Companies Mentioned

Abbott Laboratories,Danaher ,F. Hoffmann-La Roche ,Sysmex ,Alere ,Cepheid ,CoaguSense ,HYPEN BioMed,Helena Laboratories,LABiTec,Medtronic,Siemens,Sienco,Stago

Complete report available @ Global Coagulation Testing Market 2014-2018.